The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFletcher King Regulatory News (FLK)

Share Price Information for Fletcher King (FLK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.00
Bid: 33.00
Ask: 37.00
Change: 0.00 (0.00%)
Spread: 4.00 (12.121%)
Open: 35.00
High: 35.00
Low: 35.00
Prev. Close: 35.00
FLK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

2 Nov 2020 13:42

RNS Number : 9753D
Fletcher King PLC
02 November 2020
 

Fletcher King plc

 

Trading Update

 

 

Fletcher King plc (the "Company") provides the following business and trading update.

 

In the announcements of 20 August and 14 September 2020, the Company stated it was very likely to make a loss in the first half of the current financial year. Following the end of the half year on 31 October 2020, the Company confirms that a trading loss has been made, and, subject to adjustments, this is currently expected to be approximately £450,000 (before tax and any fair value adjustment to investments). Further details will be disclosed in the Company's interim results which will be published by no later than 31 January 2021.

 

The Company highlighted in its announcements of 20 August and 14 September 2020 the huge uncertainty and market dislocation caused by the COVID pandemic, which was likely to have a material adverse impact on transaction-based fees such as investment deals, bank valuations and agreement of rating appeals. Trading during the first half of the financial year has confirmed this, and transaction-based fees have been materially lower than would otherwise be expected prior to the COVID pandemic.

 

Whilst there remains an encouraging pipeline of potential investment business, there is still significant uncertainty around the timing or likelihood of completions. Performance in the second half will be highly dependent on investor sentiment and the economic environment in which the Company operates. Given the new lockdown measures which have just been announced by the UK government, and the potential for further lockdowns during the remainder of the financial year, it remains likely that transaction-based fees will continue to be affected by the COVID pandemic.

 

The Company remains well supported by a strong balance sheet with no debt.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

Enquiries

 

Fletcher King plc

David Fletcher / Peter Bailey

Tel: 0207 493 8400

 

Cairn Financial Advisers LLP

James Caithie / Liam Murray

Tel: 020 7213 0880

 

Forward Looking Statements

This announcement contains forward-looking statements relating to expected or anticipated future events and anticipated results that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties, such as general economic, market and business conditions, competition for qualified staff, the regulatory process and actions, technical issues, new legislation, uncertainties resulting from potential delays or changes in plans, uncertainties resulting from working in a new political jurisdiction, uncertainties regarding the results of exploration, uncertainties regarding the timing and granting of prospecting rights, uncertainties regarding the Company's ability to execute and implement future plans, and the occurrence of unexpected events. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKKBBQNBDDDDK
Date   Source Headline
19th Mar 20247:00 amRNSGrant of Share Options
21st Dec 20237:00 amRNSHalf-year Report
11th Oct 202312:10 pmRNSResult of AGM
22nd Sep 20235:16 pmRNSHolding(s) in Company
15th Sep 20233:19 pmRNSPublication of Report and Accounts
8th Aug 20237:00 amRNSFinal Results
15th Dec 20227:00 amRNSHalf-year Report
12th Oct 202210:56 amRNSResult of AGM
16th Sep 20225:53 pmRNSHolding(s) in Company
15th Sep 20222:34 pmRNSPublication of Annual Report & Accounts
30th Aug 20228:38 amRNSFinal Results
11th May 20227:00 amRNSChange of Registered Office
7th Apr 20229:00 amRNSPrice Monitoring Extension
8th Mar 20225:32 pmRNSHolding(s) in Company
8th Mar 20224:56 pmRNSHolding(s) in Company
8th Mar 20224:56 pmRNSHolding(s) in Company
8th Mar 20224:53 pmRNSHolding(s) in Company
8th Mar 20224:52 pmRNSHolding(s) in Company
4th Mar 20224:03 pmRNSPlacing, Director Dealing and Appointments
28th Feb 202210:27 amRNSConditional Placing and Director Dealing
16th Feb 20227:00 amRNSUpdate re Conditional Placing and Director Dealing
23rd Dec 20217:00 amRNSHalf-year Report
4th Nov 202112:35 pmRNSResult of AGM
11th Oct 202111:47 amRNSPublication of Annual Report & Accounts
5th Oct 202111:05 amRNSSecond Price Monitoring Extn
5th Oct 20218:01 amRNSGrant of Share Options
4th Oct 202112:51 pmRNSUpdate re Conditional Placing and Director Dealing
4th Oct 20217:00 amRNSConditional Placing and Director Dealing
1st Oct 20217:00 amRNSFinal Results
10th Aug 20217:00 amRNSTrading Update & Notice of Results
2nd Jul 20212:06 pmRNSSecond Price Monitoring Extn
2nd Jul 20212:01 pmRNSPrice Monitoring Extension
2nd Jul 202112:50 pmRNSStatement re. press speculation
16th Mar 20217:00 amRNSDirectorate Changes
3rd Mar 20219:58 amRNSTrading Update
11th Jan 20213:28 pmRNSHolding(s) in Company
18th Dec 20207:00 amRNSHalf-year Report
2nd Nov 20201:42 pmRNSTrading Update
28th Oct 202010:27 amRNSResult of AGM
30th Sep 20203:08 pmRNSPublication of Annual Report & Accounts
14th Sep 20207:00 amRNSFinal Results
20th Aug 20207:00 amRNSTrading Update
28th Apr 20202:07 pmRNSOption Surrender
24th Apr 20207:00 amRNSDirectorate Change
14th Apr 20207:00 amRNSTrading Update - COVID 19
20th Dec 20197:00 amRNSHalf-year Report
26th Nov 20193:50 pmRNSHolding(s) in Company
31st Oct 201912:00 pmRNSDirectorate Change
18th Sep 201911:10 amRNSResult of AGM
23rd Aug 20192:47 pmRNSPublication of Annual Report & Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.